TAMPA, Fla. and LONDON, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology ...
Researchers at Carnegie Mellon University have developed a groundbreaking lens technology that enables a camera to focus on ...
As of Monday, December 29, Aligos Therapeutics, Inc.’s ALGS share price has dipped by 5.24%, which has investors questioning ...
Discover why Edgewise Therapeutics, Inc. is rated Buy amid strong trial data, unique HCM treatment, and major 2026 catalysts. Click for this EWTX update.
A new microchip-sized device could dramatically accelerate the future of quantum computing. It controls laser frequencies ...
This move represented a sharp increase in price on volume nearly 3x the average daily trading volume, indicating robust ...
Unidad de Gestión Clínica de Salud Mental, Instituto IBIMA, Hospital Regional Universitario, Málaga E-29010, Spain ...
Abstract: We present an automatic bias controller by completely using analog circuit with lower power consumption and smaller size compared to digital ones. Our controller maintains the bias point of ...
In the CIRRUS-HCM trial, including interim safety results from Part D, EDG-7500 was generally well tolerated; no clinically meaningful reductions in LVEF or LVEF - - On track to deliver ...
Janux provided a program update on its Phase 1 study of JANX008, an EGFR-targeted TRACTr, following Phase 1a completion and ...
In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback